Your browser doesn't support javascript.
loading
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure.
Marques, Francine Z; Prestes, Priscilla R; Byars, Sean G; Ritchie, Scott C; Würtz, Peter; Patel, Sheila K; Booth, Scott A; Rana, Indrajeetsinh; Minoda, Yosuke; Berzins, Stuart P; Curl, Claire L; Bell, James R; Wai, Bryan; Srivastava, Piyush M; Kangas, Antti J; Soininen, Pasi; Ruohonen, Saku; Kähönen, Mika; Lehtimäki, Terho; Raitoharju, Emma; Havulinna, Aki; Perola, Markus; Raitakari, Olli; Salomaa, Veikko; Ala-Korpela, Mika; Kettunen, Johannes; McGlynn, Maree; Kelly, Jason; Wlodek, Mary E; Lewandowski, Paul A; Delbridge, Lea M; Burrell, Louise M; Inouye, Michael; Harrap, Stephen B; Charchar, Fadi J.
Afiliación
  • Marques FZ; School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Ballarat, Victoria, Australia.
  • Prestes PR; Heart Failure Research Group, Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.
  • Byars SG; School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Ballarat, Victoria, Australia.
  • Ritchie SC; Centre for Systems Genomics, The University of Melbourne, Victoria, Australia.
  • Würtz P; School of BioSciences, The University of Melbourne, Victoria, Australia.
  • Patel SK; Department of Pathology, The University of Melbourne, Victoria, Australia.
  • Booth SA; Centre for Systems Genomics, The University of Melbourne, Victoria, Australia.
  • Rana I; Department of Pathology, The University of Melbourne, Victoria, Australia.
  • Minoda Y; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Berzins SP; Department of Medicine, The University of Melbourne Austin Health, Heidelberg, Victoria, Australia.
  • Curl CL; School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Ballarat, Victoria, Australia.
  • Bell JR; School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Ballarat, Victoria, Australia.
  • Wai B; School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Ballarat, Victoria, Australia.
  • Srivastava PM; School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Ballarat, Victoria, Australia.
  • Kangas AJ; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Victoria, Australia.
  • Soininen P; Department of Physiology, The University of Melbourne, Victoria, Australia.
  • Ruohonen S; Department of Physiology, The University of Melbourne, Victoria, Australia.
  • Kähönen M; Department of Medicine, The University of Melbourne Austin Health, Heidelberg, Victoria, Australia.
  • Lehtimäki T; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia.
  • Raitoharju E; Department of Medicine, The University of Melbourne Austin Health, Heidelberg, Victoria, Australia.
  • Havulinna A; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia.
  • Perola M; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Raitakari O; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Salomaa V; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Ala-Korpela M; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Finland.
  • Kettunen J; Department of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland.
  • McGlynn M; Fimlab Laboratories, Department of Clinical Chemistry, Pirkanmaa Hospital District, School of Medicine, University of Tampere, Finland.
  • Kelly J; Fimlab Laboratories, Department of Clinical Chemistry, Pirkanmaa Hospital District, School of Medicine, University of Tampere, Finland.
  • Wlodek ME; National Institute for Health and Welfare, Helsinki, Finland.
  • Lewandowski PA; National Institute for Health and Welfare, Helsinki, Finland.
  • Delbridge LM; Institute for Molecular Medicine Finland, University of Helsinki, Finland.
  • Burrell LM; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Finland.
  • Inouye M; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
  • Harrap SB; National Institute for Health and Welfare, Helsinki, Finland.
  • Charchar FJ; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
J Am Heart Assoc ; 6(6)2017 Jun 14.
Article en En | MEDLINE | ID: mdl-28615213
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preñez / ARN / Regulación de la Expresión Génica / Cardiomegalia / Lipocalina 2 / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: J Am Heart Assoc Año: 2017 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preñez / ARN / Regulación de la Expresión Génica / Cardiomegalia / Lipocalina 2 / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: J Am Heart Assoc Año: 2017 Tipo del documento: Article País de afiliación: Australia